Global Glioblastoma Drug Pipeline Capsule - 2012 Update

Fore Pharma, September 2012, Pages: 18

Fore Pharma's latest report 'Global Glioblastoma Drug Pipeline Capsule - 2012 Update' provides most up-to-date information on key Research and Development activities (R&D) in the global Glioblastoma market. It covers active Glioblastoma pipeline molecules in various stages of clinical trials, preclinical research, and drug discovery.

This report helps executives track competitors pipeline molecules. The information presented in this report can be used for identifying partners, evaluating opportunities, formulating business development strategies, executing in-licensing and out-licensing deals.

The report provides information on pipeline molecules by company and mechanism of action across the R&D stages. It also provides information on pipeline molecules developed in leading geographies (North America and Europe). Licensing activities are thoroughly captured in this report.

Key Features of the Report:
- Glioblastoma: Overview
- Glioblastoma Pipeline Overview
- Glioblastoma Phase 3 Clinical Trial Pipeline Insights
- Glioblastoma Phase 2 Clinical Trial Pipeline Insights
- Glioblastoma Phase 1 Clinical Trial Pipeline Insights
- Glioblastoma Preclinical Research Pipeline Insights
- Glioblastoma Discovery Stage Pipeline Insights
- Geographic Landscape of Glioblastoma R&D Activities
- Glioblastoma R&D Activities in North America
- Glioblastoma R&D Activities in Europe
- Licensing Activities / Partnerships

1. Glioblastoma - Disease Overview
2. Glioblastoma Pipeline Overview
3. Glioblastoma Phase 3 Clinical Trial Pipeline Insights
4. Glioblastoma Phase 2 Clinical Trial Pipeline Insights
5. Glioblastoma Phase 1 Clinical Trial Pipeline Insights
6. Glioblastoma Preclinical Research Pipeline Insights
7. Glioblastoma Discovery Stage Pipeline Insights
8. Glioblastoma Drug Development Activities - Geographic Landscape
8.1. Glioblastoma R&D Activities in North America
8.2. Glioblastoma R&D Activities in Europe
9. Glioblastoma Pipeline - Licensing Activities
Table 1. Glioblastoma Pipeline Molecules - Phase 3 Clinical Trial
Table 2. Glioblastoma Pipeline Molecules - Phase 2 Clinical Trial
Table 3. Glioblastoma Pipeline Molecules - Phase 1 Clinical Trial
Table 4. Glioblastoma Pipeline Molecules - Preclinical Research
Table 5. Glioblastoma Pipeline Molecules - Drug Discovery
Table 6. Glioblastoma R&D Activities by Geography
Table 7. Glioblastoma Pipeline Molecules - North America
Table 8. Glioblastoma Pipeline Molecules - Europe
Table 9. Glioblastoma Pipeline - Licensing Activities

Figure 1. Glioblastoma Pipeline Molecules by R&D Stage
Figure 2. Glioblastoma R&D Activities by Geography

Customers who bought this item also bought

• Global Glioblastoma Multiforme Drug Pipeline Capsule - 2012
• Medical Nutrition - A Global Market Overview
• Therapeutic Cancer Vaccines Market to 2019 - Pipeline Indicates Safer Treatments and Extended Patient Survival, though High Prices May Limit Uptake
• Diabetes Diagnostics - Global Strategic Business Report
• World Vaccines Market: Vaccine Segments Analysis, Vaccine Cases and Future Forecast
• Disinfectants - Global Strategic Business Report
• Syringes (Disposable and Reusable) - Global Strategic Business Report
• Molecular Diagnostics - Global Strategic Business Report
• HPLC Systems and Accessories - Global Strategic Business Report
• Dental Supplies - Global Strategic Business Report